Latest Videos
ePanel Keystone Symposia: Charting the Future of Immunology and Immunotherapy
This Keystone Symposia ePanel celebrates the inaugural winners of the Michelson Philanthropies & Science Prize for Immunology, an international prize that focuses on transformative research in human immunology.
Dr. Scott Biering, Immunology Prize Finalist: Flavivirus Protein as a Target for Vaccines
Dr. Scott Biering's (University of California, Berkeley,) research reveals how a conserved flavivirus protein holds potential as a target for versatile vaccines and therapies.
Dr. Lisa Wagar, Immunology Prize Finalist: Immune Responses to Viruses and Vaccines
Dr. Lisa Wagar's (University of California, Irvine) research deciphers the immune responses to viruses and vaccines using human tonsil organoids.
Dr. Paul Bastard, Immunology Prize Recipient: Why Do People Die from COVID?
Dr. Paul Bastard of the Laboratory of Human Genetics of Infectious Diseases, Institut Imagine, INSERM & University of Paris, and The Rockefeller University, New York, received the Michelson Philanthropies & Science Grand Prize for his outstanding essay “Why do people die from COVID-19?: Autoantibodies neutralizing type I interferons increase with age.”
2021 Michelson Prizes Human Immunome Project Award Ceremony
The Michelson Medical Research Foundation and the Human Immunome Project (formerly the Human Vaccines Project) celebrate the winners of the 2021 Michelson Prizes Human Immunome Project award for their innovative vaccine and immunology research.
Dr. Camila Consiglio Explores Differences in Human Immune Responses Between the Sexes to Develop More Targeted Vaccines
Dr. Camila Consiglio, Karolinska Institutet, offers a novel approach to understanding differences in human immune responses between sexes by studying a unique cohort of people: individuals undergoing sex-re-assignment therapy.
Dr. Nicholas Wu Takes on Lifelong Quest to Understand How the Immune System Responds to the Flu
Dr. Nicholas Wu’s research (University of Illinois, Urbana-Champaign) has the potential to shift the paradigm of antibody discovery and characterization. Dr. Wu attempts to interpret the complexity of the human antibody repertoire, by establishing a sequence-based approach for epitope prediction.
2020 Michelson Prizes: Next Generation Grants Award Ceremony
The Michelson Medical Research Foundation and Human Immunome Project hosted a special 2-hour ceremony with 2020 Michelson Prizes Winners, Dr. Danika Hill (Monash University) and Dr. Michael Birnbaum (MIT).
Dr. Michael Birnbaum, 2020 Michelson Prizes Human Immunome Project Recipient
Dr. Birnbaum, Assistant Professor, Department of Biological Engineering, MIT, received the 2020 Michelson Prize for Human Immunology and Vaccine Research for “Repertoire-Scale Determination of T Cell Recognition and Cross-Reactivity to HIV via pMHC Lentiviral Display.”
Dr. Danika Hill, 2020 Michelson Prizes Human Immunome Project Recipient
Dr. Danika Hill, Research Fellow, Monash University, Melbourne, Australia, received the Michelson Prize for Human Immunology and Vaccine Research 2020 for: “Exploiting T Follicular Helper Cells as an Innovative Tool to Discover Targets for Long-Lived Humoral Immunity.”
Dr. Avinash Das Sahu, 2019 Michelson Prizes Human Immunome Project Recipient
Dr. Avinash Das Sahu, Department of Data Sciences, Dana-Farber Cancer Institute, describes his research project titled “Identification of cancer drugs that boost immunotherapy response.”
Dr. Murad Mamedov, 2019 Michelson Prizes Human Immunome Project Recipient
Dr. Murad Mamedov, Postdoctoral Scholar, Microbiology and Immunology, School of Medicine, University of California, San Francisco, describes his research project titled “Mapping γδ T Cell Receptor Ligands.”
Dr. Kamal Mandal, 2019 Michelson Prizes Human Immunome Project Recipient
Dr. Kamal Mandal, University of California, San Francisco, describes his research project titled “‘Structural surfaceomics: an approach to identify cancer-specific cell surface protein conformations for immunotherapeutic targeting.”
Dr. Ansuman Satpathy, 2018 Michelson Prizes Human Immunome Project Recipient
Dr. Ansuman Satpathy, Assistant Professor, Department of Pathology, Stanford University School of Medicine, was awarded a 2018 Michelson Prize for Human Immunology and Vaccine Research for his work focused on combining disciplines of genomics and human immunology.
Dr. Laura Mackay, 2018 Michelson Prizes Human Immunome Project Recipient
Dr. Laura MacKay, Laboratory Head and Senior Lecturer, Peter Doherty Institute for Infection and Immunity, University of Melbourne, is studying a recently described subset of immune cells called tissue-resident memory T cells, which combat various viral infections and cancer.
Dr. Patricia Therese Illing, 2018 Michelson Prizes Human Immunome Project Recipient
Dr. Patricia Therese Illing of Monash University was awarded a 2018 Michelson Prize for Human Immunology and Vaccine Research for her work involving an innovative new approach for identifying influenza-specific peptide antigens.
Dr. Laura Kate Mackay: Are TRM Cells the Future of Vaccine and Cancer Treatments?
Dr. Laura Kate Mackay discusses her research on TRM cells and how they could be targeted to improve immune protection against disease and revolutionize the development of new vaccines and cancer therapies.
Dr. Ansuman Satpathy on Single-Cell Epigenome Technologies for Precision Immune Profiling
Dr. Satpathy discusses his work on single-cell epigenome technologies for precision immune profiling. He explains how these technologies can be used to study the immune system at a single-cell level, and improve our understanding of diseases to develop new treatments.
Dr. Patricia Therese Illing: How Spliced Peptides Could Revolutionize Influenza Vaccines
Dr. Patricia Therese Illing discusses her research on spliced peptides for influenza immunity. She explains how spliced peptides can be used to target the immune system to specific parts of the influenza virus.
The Future of Vaccines: What We Learned at the First Annual Conference
The Future of Vaccine Development Conference brought together leading scientists and researchers from around the world to discuss the latest advances in vaccines and to explore new ways to accelerate the development of vaccines against some of the world's most threatening diseases.
